4,314
Views
984
CrossRef citations to date
0
Altmetric
Original

Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment

, , , , , , , , , , , , , & , MSc show all
Pages 109-138 | Received 18 Jul 2008, Published online: 10 Jul 2009

References

  • Ahmad, A, Mukherjee, P, Senapati, S, Mandal, I, Khan, I.M, Kumar, R, Sastry, M. 2003. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids Surf B: Biointerfaces. 28:313–318.
  • Alt V, Wagener M, Salz D, Bechert T, Steinrücke P, Schnettler R. Plasma polymer – high-porosity silver composite coating for infection prophylaxis in intramedullary nailing. Practice of intramedullary locked nails. New developments in techniques and applications, KS Leung, G Taglang, R Schnettler, V Alt, HJTM Haarman, H Seidel, I Kemf. Springer, Berlin 2006; 297–303
  • Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, Dingeldein E, Domann E, Schnettler R. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004; 25: 4383–4391
  • Asharani, PV, Nair, G, Zhiyuan, H, Manoor, P, Valiyaveettil, S. 2007. Potential health impacts of silver nanoparticles. Abstracts of Papers, 234th ACS National Meeting, Boston, MAUSA, August 19–23, 2007. pp:TOXI-099.
  • Aslan K, Geddes CD. Microwave-accelerated and metal-enhanced fluorescence myoglobin detection on silvered surfaces: Potential application to myocardial infarction diagnosis. Plasmonics 2006; 1: 53–59
  • Aslan K, Gryczynski I, Malicka J, Matveeva E, Lakowicz JR, Geddes CD. Metal-enhanced fluorescence: An emerging tool in biotechnology. Curr Opin Biotechnol 2005; 16: 55–62
  • Aslan K, Huang J, Wilson GM, Geddes CD. Metal-enhanced fluorescence-based RNA sensing. J Am Chem Soc 2006; 128: 4206–4207
  • Aslan K, Wu M, Lakowicz JR, Geddes CD. Metal enhanced fluorescence solution-based sensing platform 2: Fluorescent core-shell Ag@SiO2 nanoballs. J Fluoresc 2007; 17: 127–131
  • Asz J, Asz D, Moushey R, Seigel J, Mallory SB, Foglia RP. Treatment of toxic epidermal necrolysis in a pediatric patient with a nanocrystalline silver dressing. J Pediatric Surg 2006; 41: e9–12
  • Agency for Toxic Substances and Disease Registry (ATSDR). 1990. Toxicological profile for silver. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry ( TP-90-24).
  • Baker C, Pradhan A, Pakstis L, Pochan DJ, Shah SI. Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol 2005; 5: 244–249
  • Bayston R, Ashraf W, Fisher L. Prevention of infection in neurosurgery: Role of ‘antimicrobial’ catheters. J Hosp Infect 2007; 65: 39–42
  • Bell R, Kramer J. Structural chemistry and geochemistry of silver-sulfur compounds: Critical review. Environ Toxicol Chem 1999; 18: 9–22
  • Benn, TM, Westerhoff, P. 2008. Nanoparticle silver released into water from commercially available sock fabrics. Environ Sci Technol, 42:4133–4139. Erratum in: Environ Sci Technol 42:7025–7026.
  • Bhainsa KC, D'Souza SF. Extracellular biosynthesis of silver nanoparticles using the fungus Aspergillus fumigatus. Colloids Surf B: Biointerfaces 2006; 47: 160–164
  • Bhol KC, Alroy J, Schechter PJ. Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin Exp Dermatol 2004; 29: 282–287
  • Bhol KC, Schechter PJ. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Br J Dermatol 2005; 152: 1235–1242
  • Bhol KC, Schechter PJ. Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis. Digestive Dis Sci 2007; 52: 2732–2742
  • Bouwmeester, H, Dekkers, S, Noordam, M, Hagens, W, Bulder, A, De Heer, C, Ten Voorde, S, Wijnhoven, S, Sips, A. 2007. Health impact of nanotechnologies in food production. RIKILT/RIVM Report 2007.014. Accessed March 2008 from the website: http://www.rikilt.wur.nl/NR/rdonlyres/BDEEDD31-F58C-47EB-A0AA-23CB9956CE18/54352/R2007014.pdf.
  • Bragg PD, Rainnie DJ. The effect of silver ions on the respiratory chain of Escherichia, coli. Can J Microbiol 1974; 20: 883–889
  • Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 2005; 88: 412–419
  • British Standards Institution (BSI). 2007. PAS136 Terminology for nanomaterials. Accessed from the website: http://www.bsi-global.com.
  • Bryan G, Langston W. Bioavailability, accumulation and effects of heavy metals in sediments with special reference to United Kingdom estuaries: A review. Environ Pollut 1992; 76: 89–131
  • Burrell RE, Heggers JP, Davis GJ, Wright JB. Efficacy of silver-coated dressings as bacterial barriers in a rodent burn sepsis model. Wounds 1999; 11: 64–71
  • Bury N, Wood C. Mechanism of branchial apical silver uptake by rainbow trout is via the proton-coupled Na(+) channel. Am J Physiol – Regulatory Integrat Comparat Physiol 1999; 277: R1385–1391
  • Catsakis LH, Sulica VI. Allergy to silver amalgams. Oral Surg 1978; 46: 371–375
  • Chang AL, Khosravi V, Egbert B. A case of argyria after colloidal silver ingestion. J Cutaneous Pathol 2006; 33: 809–811
  • Chen W, Liu Y, Courtney HS, Bettenga M., Agrawal CM, Bumgardner JD, Ong JL. In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials 2006; 27: 5512–5517
  • Chen X, Schluesener HJ. Nano-silver: A nanoproduct in medical application. Toxicol Lett 2008; 176: 1–12
  • Chopra I. The increasing use of silver-based products as antimicrobial agents: A useful development or a cause for concern?. J Antimicrob Chemother 2007; 59: 587–590
  • Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev 2006; 19: 403–434
  • Coelho S, Amarelo M, Ryan S, Reddy M, Sibbald RG. Rheumatoid arthritis-associated inflammatory leg ulcers: A new treatment for recalcitrant wounds. Int Wound J 2004; 1: 81–84
  • Cohen MS, Stern JM, Vanni AJ, Kelley RS, Baumgart E, Field D, Libertino JA, Summerhayes IC. In vitro analysis of a nanocrystalline silver-coated surgical mesh. Surg Infect (Larchmt. 2007; 8: 397–403
  • Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: The multipurpose protein. Cell Mol Life Sci 2002; 59: 627–647
  • Danilczuk M, Lund A, Sadlo J, Yamada H, Michalik J. Conduction electron spin resonance of small silver particles. Spectrochim. Acta A 2006; 63: 189–191
  • Dekkers, S, Prud'homme de Lodder, LCH, De Winter, R, Sips, AJAM, De Jong, WH. 2007a. Inventory of consumer products containing nanomaterials. RIVM/SIR advisory report, , 11124.
  • Dekkers, S, De Heer, C, De Jong, WH, Sips, AJAM, Van Engelen, JGM. 2007b. Nanomaterials in consumer products. Availability on the European market and adequacy of the regulatory framework. RIVM/SIR Advisory report 11014.
  • Demling RH, Leslie DeSanti MD. The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver. Burns 2002; 28: 264–266
  • Drake PL, Hazelwood KJ. Exposure-related health effects of silver and silver compounds: A review. Ann Occup Hyg 2005; 49: 575–585
  • Dunn K, Edwards-Jones V. The role of Acticoat with nanocrystalline silver in the management of burns. Burns 2004; 30: S1–9
  • Eckelman M, Graedel T. Silver emissions and their environmental impact: A multilevel assessment. Environ Sci Technol 2007; 41: 6283–6289
  • Eisler, R. 1997. Silver hazards to fish, wildlife and invertebrates: A synoptic review. Washington, DC, US Department of the Interior, National Biological Service, 44 pp. (Biological Report 32 and Contaminant Hazard Reviews Report 32).
  • Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdörster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 2006; 114: 1172–1178
  • Elechiguerra, JL, Burt, JL, Morones, JR, Camacho-Bragado, A, Gao, X, Lara, HH, Yacaman, MJ. 2005. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol, 3: 6.
  • Fortin C, Campbell P. Silver uptake by the green alga Chlamydomonas reinhardtii in relation to chemical speciation: Influence of chloride. Environ Toxicol Chem 2000; 19: 2769–2778
  • Fung MC, Bowen DL. Silver products for medical indication: Risk benefit assessment. Clin Toxicol 1996; 34: 119–126
  • Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, Bayston R, Brown PD, Winship PD, Reid HJ. Silver nanoparticles and polymeric medical devices: A new approach to prevention of infection?. J Antimicrob Chemother 2004; 54: 1019–1024
  • Furst A, Schlauder MC. Inactivity of two noble metals as carcinogens. J Environ Pathol Toxicol 1978; 1: 51–57
  • Galiano K, Pleifer C, Engelhardt K, Brossner G, Lackner P, Huck C, Lass-Florl C, Obwegeser A. Silver segregation and bacterial growth of intraventricular catheters impregnated with silver nanoparticles in cerebrospinal fluid drainages. Neurol Res ASAP 2007; 30: 285–287
  • Gan X, Liu T, Zhong J, Liu X, Li G. Effect of silver nanoparticles on the electron transfer reactivity and the catalytic activity of myoglobin. ChemBioChem 2004; 5: 1686–1691
  • Garner M, Reglinski J, Smith WE, Stewart MJ. The interaction of colloidal metals with erythrocytes. J Inorg Biochem 1994; 56: 283–290
  • GFMS. 2004. World silver survey 2004 – a summary. Washington, DC: The Silver Institute, LondonUK: Gold Fields Mineral Services. ISBN 1-880936-12-7.
  • Green RJ, Davies MC, Roberts CJ, Tendler SJB. Competitive protein adsorption as observed by surface plasmon resonance. Biomaterials 1999; 20: 385–391
  • Gulbranson SH, Hud JA, Hansen RC. Argyria following the use of dietary supplements containing colloidal silver protein. Cutis 2000; 66: 373–376
  • Hatchett DW, Henry S. Electrochemistry of sulfur adlayers on low-index faces of silver. J Phys Chem 1996; 100: 9854–9859
  • Hatchett DW, White HS. Electrochemistry of sulfur adlayers on the low-index faces of silver. J Phys Chem 1996; 100: 9854–9859
  • Hill WR, Pillsbury DM. Argyria: The pharmacology of silver. Williams and Wilkins Co, Baltimore, MD 1939
  • Hogstrand C, Galvez F, Wood C. Toxicity, silver accumulation and metallothionein induction in freshwater rainbow trout during exposure to different silver salts. Environ Toxicol Chem 1996; 15: 1102–1108
  • Holt KB, Bard AJ. Interaction of silver(I) ions with the respiratory chain of Escherichia coli: An electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag +. Biochemistry 2005; 44: 13214–13223
  • Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol in vitro 2005; 19: 975–983
  • Hussain SM, Javorina AK, Schrand AM, Duhart HM, Ali SF, Schlager JJ. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci 2006; 92: 456–463
  • Hwang ET, Lee JH, Chae YJ, Kim YS, Kim BC, Sang B, Gu MB. Analysis of the toxic mode of action of silver nanoparticles using stress-specific bioluminescent bacteria. Small 2008; 4: 746–750
  • International Commission on Radiological Protection (ICRP). 1994. Human respiratory tract model for radiological protection. ICRP Publication 66, Annals of ICRP, 231.
  • Innes ME, Umraw N, Fish JS, Gomez M, Cartotto RC. The use of silver coated dressings on donor site wounds: A prospective, controlled matched pair study. Burns 2001; 27: 621–627
  • Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han BS, Shin JH, Sung JH., Song KS, Yu IJ. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 2007; 19: 857–871
  • Jia H, Hou W, Wei L, Xu B, Liu X. The structures and antibacterial properties of nano-SiO2 supported silver/zinc-silver materials. Dent Mater 2008; 24: 244–249
  • Kakurai M, Demitsu T, Umemoto N, Ohtsuki M, Nakagawa H. Activation of mast cells by silver particles in a patient with localized argyria due to implantation of acupuncture needles. Br J Dermatol 2003; 148: 822
  • Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, Kim YK, Lee YS, Jeong DH, Cho MH. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007; 3: 95–101
  • Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ. Twenty-eight-day oral toxicity, genotoxicity, and gender-related issue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 2008; 20: 575–583
  • Klasen HJ. Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 2000; 26: 117–130
  • Klaus T, Joerger R, Olsson E, Granqvist CG. Silver-based crystalline nanoparticles, microbially fabricated. Proc Natl Acad Sci USA 1999; 96: 13611–13614
  • Kuempel ED, Tran CL, Castranova V, Bailer AJ. Lung dosimetry and risk assessment of nanoparticles: Evaluating and extending current models in rats and humans. Inhal Toxicol 2006; 18: 717–724
  • Lam PK, Chan ESY, Ho WS, Liew CT. In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes. Br J Biomed Sci 2004; 61(3)125–127
  • Lansdown AB. Controversies over colloidal silver. J Wound Care 2003; 12: 120
  • Lansdown AB. Critical observations on the neurotoxicity of silver. Crit Rev Toxicol 2007; 37: 237–250
  • Lee HJ, Yeo SY, Jeong SH. Antibacterial effect of nanosized silver colloidal solution on textile fabrics. J Mater Sci 2003; 38: 2199–2204
  • Lee KJ, Nallathamby PD, Browning LM, Osgood CJ, Xu XN. In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. Am Chem Soc 2007; 1(2)133–143
  • Lesniak W, Bielinska AU, Sun K, Janczak KW, Shi X, Baker JR, Balogh LP. Silver/dendrimer nanocomposites as biomarkers: Fabrication, characterization, in vitro toxicity, and intracellular detection. Nano Lett 2005; 5: 2123–2130
  • Li Y, Leung P, Yao L, Song QW, Newton E. Antimicrobial effect of surgical masks coated with nanoparticles. J Hosp Infect 2006; 62: 58–63
  • Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 2006; 5: 916–924
  • Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM. Silver nanoparticles: Partial oxidation and antibacterial activities. J Biol Inorg Chem 2007; 12: 527–534
  • Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 2005; 83: 377–385
  • Luoma, S. 1994. Fate, bioavailability and toxicity of silver in estuarine environments. In: A Andren, Bober, T, Transport, fate and effects of silver in the environment. Proceedings of the 2nd international conference. 11–14 September 1994. Madison, WI, University of Wisconsin Sea Grant Institute. pp 151–155.
  • Marshall JPII, Schneider RP. Systemic argyria secondary to topical silver nitrate. Arch Dermatol 1977; 133: 1077–1079
  • Maynard AD, Kuempel ED. Airborne nanostructured particles and occupational health. J Nanoparticle Res 2005; 7: 587–614
  • Maynard, AD, Michelson, E. 2005. The nanotechnology consumer products inventory. Woodrow Wilson International Center for Scholars.
  • Mirsattari SM, Hammond RR, Sharpe MD, Leung FY, Young GB. Myoclonic status epilepticus following repeated oral ingestion of colloidal silver. Neurology 2004; 62: 1408–1410
  • Mohanpuria P, Rana NK, Yadav SK. Biosynthesis of nanoparticles: Technological concepts and future applications. J Nanoparticle Res 2008; 10: 507–517
  • Moores A, Goettmann F. The plasmon band in noble metal nanoparticles: An introduction to theory and applications. New J Chem 2006; 30: 1121–1132
  • Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ. The bactericidal effect of silver nanoparticles. Nanotechnology 2005; 16: 2346–2353
  • Muangman P, Chuntrasakul C, Silthram S, Suvanchote S, Benjathanung R, Kittidacha S, Rueksomtawin S. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds. J Med Assoc Thai 2006; 89: 953–958
  • Mukherjee P, Ahmad A, Mandal D, Senapati S, Sainkar SR, Khan MI, Parishcha R, Ajaykumar PV, Alam M, Kumar R, Sastry M. Fungus-mediated synthesis of silver nanoparticles and their immobilization in the mycelial matrix: A novel biological approach to nanoparticle synthesis. Nano Lett 2001; 1: 515–519
  • Mukherjee, P, Roy, M, Mandal, BP, Dey, GK, Mukherjee, PK, Ghatak, J, Tyagi, AK, Kale, SP. 2008. Green synthesis of highly stabilized nanocrystalline silver particles by a non-pathogenic and agriculturally important fungus T. asperellum. Nanotechnology, 19:075103 (7pp). doi: 10.1088/0957-4484/19/7/07513.
  • Murata T, Kanao-Koshikawa M, Takamatsu T. Effects of Pb, Cu, Sb, In and Ag contamination on the proliferation of soil bacterial colonies, soil dehydrogenase activity, and phospholipid fatty acid profiles of soil microbial communities. Water Air Soil Pollut 2005; 164: 103–118
  • Nanoforum.org; European Nanotechnology Gateway. 2004. Nanoforum Report: Benefits, risks, ethical, legal and social aspects. 4th General Report, June 2004. Accessed January 2008 from the website: http://www.nanoforum.org.
  • Nanoforum.org; European Nanotechnology Gateway. 2006. Nanoforum Report: Nanotechnology in consumer products. 9th General Report. October 2006. Accessed January 2008 from the website: http://www.nanoforum.org.
  • Nordberg G, Gerhardsson L. Silver. Handbook on toxicity of inorganic compounds, HG Seiler, H Sigel, A Sigel. Marcel Dekker, New York 1988; 619–624
  • Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004; 16: 437–445
  • Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005a; 113: 823–839
  • Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Particle Fibre Toxicol 2005b; 2: 8–43
  • Paddle-Ledinek JE, Nasa Z, Cleland HJ. Effect of different wound dressings on cell viability and proliferation. Plast Reconstr Surg 2006; 117: 110S–118
  • Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol 2007; 73: 1712–1720
  • Panacek A, Kvitek L, Prucek R, Kolar M, Vecerova R, Pizurova N, Sharma VK, Nevecna T, Zboril R. Silver colloid nanoparticles: Synthesis, characterization, and their antibacterial activity. J Phys Chem B 2006; 110: 16248–16253
  • Park S, Lee YK, Jung M, Kim KH, Eun-Kyung Ahn NC, Lim Y, Lee KH. Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhalat Toxicol 2007; 19(Suppl. 1)59–65
  • Percival SL, Bowler PG, Dolman J. Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J 2007; 4: 186–191
  • Podsiadlo P, Paternel S, Rouillard JM, Zhang Z, Lee J, Lee JW, Gulari E, Kotov NA. Layer-by-layer assembly of nacre-like nanostructured composites with antimicrobial properties. Langmuir 2005; 21: 11915–11921
  • Pohle D, Damm C, Neuhof J, Rösch A, Münstedt H. Antimicrobial properties of orthopaedic textiles after in-situ deposition of silver nanoparticles. Poly Poly Comp 2007; 15: 357–363
  • Poon VK, Burd A. In vitro cytotoxity of silver: Implication for clinical wound care. Burns 2004; 30: 140–147
  • Presley B, Taylor R, Boohe P. Trace metals in Gulf of Mexico oysters. Sci Total Environ 1990; 97/98: 551–593
  • Price, OT, Asgharian, B, Miller, FJ, Cassee, FR, de Winter-Sorkina, R. 2002. Multiple Path Particle Dosimetry model (MPPD v1.0): A model for human and rat airway particle dosimetry. RIVM report 650010030. Accessed March 2008 from the website: http://www.rivm.nl/bibliotheek/rapporten/650010030.html.
  • Purcell TW, Peters JJ. Sources of silver in the environment. Environ Toxicol Chem 1998; 17(4)539–546
  • Radziuk D, Shchukin DG, Skirtach A, Mohwald H, Sukhorukov G. Synthesis of silver nanoparticles for remote opening of polyelectrolyte microcapsules. Langmuir 2007; 23: 4612–4617
  • Reinfelder J, Chang S. Speciation and microalgal bioavailability of inorganic silver. Environ Sci Technol 1999; 33(11)1860–1863
  • Rospendowski BN, Campbell JM, Reglinski J, Smith WE. Direct spectroscopic determination of functional sulphydryl groups on intact cell surfaces by surface-enhanced resonance Raman scattering. Eur Biophys J 1992; 21: 257–261
  • Roszek, B, de Jong, WH, Geertsma, RE. 2005. Nanotechnology in medical applications: State-of-the-art in materials and devices. RIVM report 265001001. Accessed March 2008 from the website: http://www.rivm.nl/bibliotheek/rapporten/265001001.html.
  • Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem 1994; 31: 351–370
  • Rustogi R, Mill J, Fraser JF, Kimble RM. The use of Acticoat™ in neonatal burns. Burns 2005; 31: 878–882
  • Sanders J, Abbe G. The role of suspended sediments and phytoplankton in the partitioning and transport of silver in estuaries. Continental Shelf Res 1987; 7: 1357–1361
  • Schaff HV, Carrel TP, Jamieson WRE, Jones KW, Rufilanchas JJ, Cooley DA, Hetzer R, Stumpe F, Duveau D, Moseley P, Van Boven WJ, Grunkemeier GL, Kennard ED, Holubkov R. Paravalvular leak and other events in silzone-coated mechanical heart valves: A report from AVERT. Ann Thorac Surg 2002; 73: 785–792
  • Schierholz JM, Lucas LJ, Rump A, Pulverer G. Efficacy of silver-coated medical devices. J Hosp Infect 1998; 40: 257–262
  • Schmaehl D, Steinhoff D. Studies on cancer induction with colloidal silver and gold solutions in rats. Z Krebsforsch 1960; 63: 586–591
  • Scientific Committee on Emerging and Newly Identified Health Risk (SCENIHR). 2006. Opinion on: The appropriateness of existing methodologies to assess the potential risk associated with engineered and adventitious products of nanotechnologies. European Commission Health & Consumer Protection Directorate-General. Directorate C-Public Health and Risk Assesment C7- Risk Assessment.
  • Scientific Committee on Emerging and Newly Identified Health Risk (SCENIHR). 2008. Opinion on: The scientific aspects of the existing and proposed definitions relating to products of nanoscience and nanotechnologies. European Commission Health & Consumer Protection Directorate-General. Directorate C-Public Health and Risk Assesment C7- Risk Assessment.
  • Scow, K, Goyer, M, Nelken, L, , et al. 1981. Exposure and risk assessment for silver. Technical report prepared for Office of Water Regulations and Standards, US Environmental Protection Agency, Washington, DC, by Arthur D. Little, Inc., Cambridge, Massachusetts (PB85-211993).
  • Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine 2007; 3: 168–171
  • Shelley WB, Shelley ED, Burmeister V. Argyria: The intradermal photograph, a manifestation of passive photosensitivity. J Am Acad Dermatol 1987; 16: 211–217
  • Shin SH, Ye MK, Kim HS, Kang HS. The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol 2007; 7: 1813–1818
  • Shrivastava, S, Bera, T, Roy, A, Singh, G, Ramachandrarao, P, Dash, D. 2007. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology, 18:225103. (9pp). doi: 10.1088/0957-4484/18/22/225103.
  • Sibbald RG, Browne AC, Coutts P, Queen D. Screening evaluation of an ionized nanocrystalline silver dressing in chronic wound care. Ostomy Wound Manage 2001; 47: 38–43
  • Sibbald RG, Contreras-Ruiz J, Coutts P, Fierheller M, Rothman A, Woo K. Bacteriology, inflammation, and healing: A study of nanocrystalline silver dressings in chronic venous leg ulcers. Adv Skin Wound Care 2007; 20: 549–558
  • Silver S. Bacterial silver resistance: Molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 2003; 27: 341–353
  • Silver Institute. 2007. Worldwide Association of miners, refiners, fabricators and manufacturers. Accessed January 2008 from the website: www.silverinstitute.org.
  • Skebo JE, Grabinski CM, Schrand AM, Schlager JJ, Hussain SM. Assessment of metal nanoparticle agglomeration, uptake, and interaction using high-illuminating system. Int J Toxicol 2007; 26: 135–141
  • Skirtach AG, Antipov AA, Shchukin DG, Sukhorukov GB. Remote activation of capsules containing Ag nanoparticles and IR dye by laser light. Langmuir 2004; 20: 6988–6992
  • Skirtach AG, Oz JA, Kreft O, Hler K, Piera Alberola A, Hwald H, Parak WJ, Sukhorukov GB. Laser-induced release of encapsulated materials inside living cells. Angew Chem Int Ed Engl 2006; 45: 4612–4617
  • Smith, I, Carson, B. 1977. Trace metals in the environment. Vol. 2. Silver. Ann Arbor, MI: Ann Arbor Science Publishers. 469 pp.
  • Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 2004; 275: 177–182
  • Soto KF, Carrasco A, Powell TG, Garza KM, Murr LE. Comparative in vitro cytotoxicity assessment of some manufactured nanoparticulate materials characterized by transmission electron microscopy. J Nanopart Res 2005; 7: 145–169
  • Soto K, Garza KM, Murr LE. Cytotoxic effects of aggregated nanomaterials. Acta Biomater 2007; 3: 351–358
  • Sun, RW, Chen, R, Chung, NP, Ho, CM, Lin, CL, Che, CM. 2005. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun (Camb.):5059–5061.
  • Sung JH, Ji JH, Yoon JU, Kim DS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Kim J, Kim TS, Chang HK, Lee EJ, Lee JH, Yu IJ. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol 2008; 20: 567–574
  • Supp AP, Neely AN., Supp DM, Warden GD, Boyce SY. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice. J Burn Care Rehabil 2005; 26: 238–246
  • Suzuki H, Toyooka T, Ibuki Y. Simple and easy method to evaluate uptake potential of nanoparticles in mammalian cells using a flow cytometric light scatter analysis. Environ Sci Technol 2007; 41: 3018–3024
  • Tai SP, Wu Y, Shieh BD, Chen LJ, Lin KJ, Yu CH, Chu SW, Chang CH, Shi XY, Wen YC, Lin KH, Liu TM, Sun CK. Molecular imaging of cancer cells using plasmon-resonant-enhanced third-harmonic-generation in silver nanoparticles. Adv Mater 2007; 19: 4520–4523
  • Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 2001; 109(Suppl. 4)547–551
  • Thomas J. Treating a non-healing diabetic foot ulcer using Acticoat Moisture Control and the Lean improvement technique. Wounds UK 2007; 3: 136–138
  • Thomas, S, Nair, SK, Jamal, EMA, Al Harthi, SH, Varma, MR, Anantharaman, MR. 2008. Size-dependent surface plasmon resonance in silver silica nanocomposites. Nanotechnology, 19:075710. (7pp). doi: 10.1088/0957-4484/19/7/075710.
  • Tian J, Wong KK, Ho CM, Lok CN, Yu WY, Che CM, Chiu JF, Tam PK. Topical delivery of silver nanoparticles promotes wound healing. Chem Med Chem 2007; 2: 129–136
  • Tredget EE, Shankowsky HA, Groeneveld A, Burrell R. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil 1998; 19: 531–537
  • Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma Injury Infect Crit Care 2006; 60: 648–652
  • U.S. Environmental Protection Agency (USEPA). 1980. Ambient water quality criteria for silver. Washington, DC, US Environmental Protection Agency, (440/5-80-071).
  • B Venugopal, Luckey, TD. 1978. Metal toxicity in mammals. In: Chemical toxicology of metals and metalloids. New York: Academic Press. pp 32–36.
  • Vigneshwaran N, Kathe AA, Varadarajan PV, Nachane RP, Balasubramanya RHJ. Functional finishing of cotton fabrics using zilver nanoparticles. Nanosci Nanotechnol 2007; 7: 1893–1897
  • Vlachou E, Chipp E, Shale E, Wilson YT, Papini R, Moiemen NS. The safety of nanocrystalline silver dressings on burns: A study of systemic silver absorption. Burns 2007; 33: 979–985
  • Wan AT, Conyers RA, Coombs CJ, Masterton JP. Determination of silver in blood, urine and tissues of volunteers and burn patients. Clin Chem 1991; 37: 1683–1687
  • Walt DR. Miniature analytical methods for medical diagnostics. Science 2005; 308: 217–219
  • Warheit DB, Borm PJ, Hennes C, Lademann J. Testing strategies to establish the safety of nanomaterials: Conclusions of an ECETOC workshop. Inhalat Toxicol 2007; 19: 631–643
  • Weisbarth RE, Gabriel MM, George M, Rappon J, Miller M, Chalmers R, Winterton L. Creating antimicrobial surfaces and materials for contact lenses and lens cases. Eye and Contact Lens 2007; 33: 426–429
  • Wen LS, Santschi PH, Gill GA, Paternostro CL, Lehman RD. Colloidal and particulate silver in river and estuarine waters of Texas. Environ Sci Technol 1997; 31: 723–731
  • White JML, Powell AM, Brady K, Russell-Jones R. Severe generalized argryia secondary ingestion of colloidal silver protein. Clin Experim Dermatol 2003; 28: 354–256
  • Wiley B, Sun Y, Mayers B, Xia Y. Shape-controlled synthesis of metal nanostructures: The case of silver. Chem Eur J 2005; 11: 454–463
  • Wood, C, Munger, S, Galvez, F, Hogstrand, C. 1994. The physiology of silver toxicity in freshwater fish. In: A Andren, Bober, T. Transport, fate, and effects of silver in the environment. Proceedings of the 2nd international conference. 11–14 September 1994. Madison, WI, University of Wisconsin Sea Grant Institute. pp 109–114.
  • Woodrow Wilson International Centre for Scholars. 2007. Project on Emerging Nanotechnologies. Consumer Products Inventory of Nanotechnology Products. Accessed December 2007 from the website: http://www.nanotechproject.org/inventories/consumer/.
  • World Health Organization (WHO). 2002. Silver and silver compounds: Environmental aspects. (Concise international chemical assessment document; 44). 1. Silver – adverse effects 2. Water pollutants, Chemical 3. Risk assessment 4. Environmental exposure I. International Programme on Chemical Safety II. Series. ISBN 92 4 153044 8 (NLM Classification: QV 297). ISSN 1020-6167. Accessed January 2008 from the website: http://www.who.int/ipcs/publications/cicad /en/cicad44.pdf.
  • Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early healing events in a porcine model of contaminated wounds: Effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen 2002; 10: 141–151
  • Wright JB, Lam K, Hansen D, Burrell RE. Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999; 27: 344–350
  • Wright JB, Lam K, Burrell RE. Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. Am J Infect Control 1998; 26: 572–577
  • Xu Z, Hou Y, Sun S. Magnetic core/shell Fe3O4/Au and Fe3O4/Au/Ag nanoparticles with tunable plasmonic properties. J Am Chem Soc 2007; 129: 8698–8699
  • Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil 1999; 20: 195–200
  • Yu H, Xu X, Chen X, Lu T, Zhang P, Jing X. Preparation and antibacterial effects of PVA-PVP hydrogels containing silver nanoparticles. J Appl Poly Sci 2007; 103: 125–133
  • Zeiri L, Bronk BV, Shabtai Y, Eichler J, Efrima S. Surface-enhanced Raman spectroscopy as a tool for probing specific biochemical components in bacteria. Appl Spectrosc 2004; 58: 33–40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.